Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thrombolytic therapy.

P F Lawrence1, G R Goodman

  • 1Department of Surgery, University of Utah School of Medicine, Salt Lake City.

The Surgical Clinics of North America
|August 1, 1992
PubMed
Summary
This summary is machine-generated.

Thrombolytic therapy effectively dissolves arterial and venous clots, especially recent ones. Techniques delivering high doses directly to the clot improve success and reduce complications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Feasibility, acceptability, and user perspective of a next-generation wrist-worn receiver and digital pills for HIV pre-exposure prophylaxis: a pilot study.

Frontiers in psychiatry·2026
Same author

Media and technology usage and attitudes in emergency department patients.

Frontiers in digital health·2022
Same author

Prognostic impact of baseline tumour immune infiltrate on disease-free survival in patients with completely resected, BRAF<sup>v600</sup> mutation-positive melanoma receiving adjuvant vemurafenib.

Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same author

A prospective observational safety study of patients with BRAF<sup>V</sup> <sup>600</sup> -mutated unresectable or metastatic melanoma treated with vemurafenib (Zelboraf Safety Study).

The British journal of dermatology·2018
Same author

When should open surgery be the initial option for critical limb ischaemia?

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2010
Same author

Minimally invasive distal limb bypasses. Techniques and results.

The Journal of cardiovascular surgery·2006
Same journal

Social Determinants of Health, Health Disparities, and Surgical Equity.

The Surgical clinics of North America·2026
Same journal

Beyond the Scalpel's Reach.

The Surgical clinics of North America·2026
Same journal

Stepwise Solutions-Society.

The Surgical clinics of North America·2026
Same journal

Stepwise Solutions-Hospitals.

The Surgical clinics of North America·2026
Same journal

Stepwise Solutions for Providers.

The Surgical clinics of North America·2026
Same journal

Stepwise Solutions-Patients Social Determinants of Health, Health Disparities, and Surgical Equity.

The Surgical clinics of North America·2026
See all related articles

Area of Science:

  • Vascular Surgery
  • Interventional Radiology
  • Pharmacology

Background:

  • Thrombolytic therapy is a crucial treatment for arterial and venous diseases.
  • Treatment success is influenced by clot age, with recent thrombi being more responsive.
  • Current therapeutic approaches include surgical intervention and lytic agents.

Purpose of the Study:

  • To evaluate the efficacy of thrombolytic therapy in treating arterial and venous diseases.
  • To identify key factors influencing successful thrombolysis, including clot age and delivery technique.
  • To explore advanced techniques for targeted lytic agent delivery and assess the potential of newer agents.

Main Methods:

  • Review of thrombolytic therapy techniques for arterial and venous thrombosis.

Related Experiment Videos

  • Analysis of the impact of clot age on lysis probability.
  • Comparison of systemic versus localized (intraoperative, isolated-limb) high-dose thrombolytic delivery.

    • Main Results:

    • Recent clots demonstrate higher susceptibility to thrombolytic therapy.
    • High-dose, short-duration thrombolysis directly into the clot yields the highest success rates.
    • Localized delivery techniques (intraoperative, isolated-limb) reduce systemic complications compared to systemic therapy.

    Conclusions:

    • Thrombolytic therapy is effective for arterial and venous disease, as a standalone or adjunctive treatment.
    • Optimizing delivery technique and targeting recent clots are critical for maximizing efficacy and minimizing risk.
    • Emerging clot-specific agents promise enhanced success rates and improved safety profiles.